Donor CTLA-4 Gene Polymorphism Associations with Acute GvHD After Allogeneic Hematopoietic Stem Cell Transplantation

被引：0
|
作者：
Frydecka, Irena [1 ]
Karabon, Lidia [1 ]
Pawlak-Adamska, Edyta [1 ]
Tomkiewicz, Anna [1 ]
Wrobel, Tomasz [2 ]
Markiewicz, Miroslaw [3 ]
Kyrcz-Krzemien, Slawomira [3 ]
机构：
[1] Polish Acad Sci, Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland
[2] Wroclaw Med Univ, Dept Hematol Neoplast Dis & Bone Marrow Transplan, Wroclaw, Poland
[3] Med Univ Silesia, Dept Hematol & Bone Marrow Transplantat, Katowice, Poland
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：878 / 878
页数：1
相关论文
共 50 条
  • [1] Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation
    Wu, Jui
    Tang, Jih-Luh
    Wu, Shang-Ju
    Lio, Hoi-Yan
    Yang, Ya-Chien
    [J]. CLINICA CHIMICA ACTA, 2009, 403 (1-2) : 229 - 233
  • [2] CTLA-4 polymorphism and clinical outcome post allogeneic hematopoietic stem cell transplantation
    Mossallam, Ghada I.
    Samra, Mohamed A.
    [J]. HUMAN IMMUNOLOGY, 2013, 74 (12) : 1643 - 1648
  • [3] Recipient CTLA-4 genotype is a prognostic factor for acute GVHD in hematopoietic stem cell transplantation
    Orru, Sandro
    Orru, Nicola
    Caocci, Giovanni
    Littera, Roberto
    Vacca, Adriana
    Lai, Sara
    Alba, Francesco
    Cappai, Luisella
    Valentini, Donatella
    Arras, Marcella
    Maddi, Roberta
    La Nasa, Giorgio
    Carcassi, Carlo
    [J]. TISSUE ANTIGENS, 2010, 75 (05): : 559 - 559
  • [4] Donors' CTLA-4 gene polymorphism is associated with increased relapse rate after hematopoietic stem cell transplantation
    Meggyesi, Nora
    Kovy, Petra
    Varga, Livia
    Balassa, Katalin
    Batai, Arpad
    Torbagyi, Eva
    Gopcsa, Laszlo
    Paksi, Melinda
    Barta, Aniko
    Masszi, Tamas
    Andrikovics, Hajnalka
    Remenyi, Peter
    [J]. BONE MARROW TRANSPLANTATION, 2019, 54 : 297 - 298
  • [5] CTLA-4 polymorphism rs231775: Influence on relapse and survival after allogeneic hematopoietic stem cell transplantation in childhood
    Hammrich, Judith
    Wittig, Susan
    Ernst, Thomas
    Gruhn, Bernd
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (03) : 251 - 255
  • [6] Donor HSP70-hom gene polymorphism contributes to the development of chronic GvHD after allogeneic hematopoietic stem cell transplantation
    Kuzyk, Anna
    Bogunia-Kubik, Katarzyna
    Jackson, Graham
    Dickinson, Anne
    [J]. TISSUE ANTIGENS, 2009, 73 (05): : 442 - 442
  • [7] A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation
    Lidia Karabon
    Miroslaw Markiewicz
    Anna Partyka
    Edyta Pawlak-Adamska
    Anna Tomkiewicz
    Monika Dzierzak-Mietla
    Slawomira Kyrcz-Krzemien
    Irena Frydecka
    [J]. Immunogenetics, 2015, 67 : 295 - 304
  • [8] Pretransplant donor and recipient CTLA-4 mRNA and protein levels as a prognostic marker for aGvHD in allogeneic hematopoietic stem cell transplantation
    Karabon, Lidia
    Markiewicz, Miroslaw
    Kosmaczewska, Agata
    Partyka, Anna
    Pawlak-Adamska, Edyta
    Tomkiewicz, Anna
    Ciszak, Lidia
    Jagoda, Krystyna
    Dzierzak-Mietla, Monika
    Kyrcz-Krzemien, Slawomira
    Frydecka, Irena
    [J]. IMMUNOLOGY LETTERS, 2015, 165 (01) : 52 - 59
  • [9] A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation
    Karabon, Lidia
    Markiewicz, Miroslaw
    Partyka, Anna
    Pawlak-Adamska, Edyta
    Tomkiewicz, Anna
    Dzierzak-Mietla, Monika
    Kyrcz-Krzemien, Slawomira
    Frydecka, Irena
    [J]. IMMUNOGENETICS, 2015, 67 (5-6) : 295 - 304
  • [10] Associations between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantation
    Nomura, Shosaku
    Ishii, Kazuyoshi
    Fujita, Shinya
    Nakaya, Aya
    Satake, Atsushi
    Ito, Tomoki
    [J]. TRANSPLANT IMMUNOLOGY, 2017, 43-44 : 27 - 32
12345